Methamphetamine‐associated cardiomyopathy (MACM) is an increasingly recognized
disease entity in the context of a rapidly spreading methamphetamine epidemic. MACM may …

With rapidly rising prevalence of exposure to Amphetamine Type Stimulants (ATS), novel
insights into cardiotoxic effects of this substance are being presented in the literature and …

Written for practitioners in the field, this critically acclaimed bestseller provides authoritative
information focused on the investigation of drug-related deaths and practical approaches to …

Methamphetamine-associated cardiomyopathy is the leading cause of death linked with
illicit drug use. Here we show that Sigmar1 is a therapeutic target for methamphetamine …

Methamphetamine (METH) abuse has been a serious global public health problem for
decades. Previous studies have shown that METH causes detrimental effects on the nervous …

Background Methamphetamine abuse is a worldwide health concern. Methamphetamine
causes health hazards in many vital organs. It can cause damage to cardiac tissue via …

The recent rise in illicit use of methamphetamine (METH), a highly addictive
psychostimulant, is a huge health care burden due to its central and peripheral toxic effects …

In recent years, methamphetamine use has dramatically increased in Iran while there is a
crucial misunderstanding about the colloquial words related to methamphetamine among …

Background: Methamphetamine (METH)-induced cardiovascular toxicity has been attributed
to its destructive effect on mitochondrial function at least to some extent. Previous studies …

Objectives: Use of methamphetamine (MA) commonly co-occurs with the use of other
substances. The present study aims to examine substance initiation patterns of other …